Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS??? EQUITY

v3.25.3
STOCKHOLDERS’ EQUITY
 3 Months Ended
Sep. 30, 2025
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 13 - STOCKHOLDERS’ EQUITY

 

During the three months ended September 30, 2025, the Company issued 7,581 shares of common stock, respectively, to the independent Board of Directors as part of their board compensation. The grant date fair value was $36,000 and was recorded as compensation expense in the accompanying consolidated financial statements.

 

During the three months ended September 30, 2025, the Company issued 5,861 shares of common stock to a consultant pursuant to the terms of his consultancy agreement. The grant date fair value of the shares was $25,000 and was recorded as compensation expense in the accompanying consolidated financial statements.

 

During the three months ended September 30, 2025, the Company issued 20,000 shares of common stock to employees pursuant to the terms of their employment agreements. The grant date fair value was $84,400 and was recorded as compensation expense in the accompanying consolidated financial statements.

 

Stock Grants

 

The following table summarizes stock grants awarded as compensation:

 

   

# Number of

shares

    

Weighted Average

Grant Date Fair

Value ($)

  
Unvested, June 30, 2025     -     $                 -  
Granted     33,442     $ 4.35  
Vested     (33,442 )   $ 4.35  
Unvested, September 30, 2025     -     $ -  

 

For the three months ended September 30, 2025 and 2024, the Company recorded compensation expense of $145,400 and $39,750, respectively. The weighted average grant date fair value is determined by the Company’s closing stock price on the grant date.

 

 

NETSOL TECHNOLOGIES, INC.

Notes to Condensed Consolidated Financial Statements

September 30, 2025

(Unaudited)